If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

SLN.L News

IN BRIEF: Silence Therapeutics Begins Dosing In SLN360 Phase 1 Trial
17 Feb 2021

IN BRIEF: Silence Therapeutics Begins Dosing In SLN360 Phase 1 Trial

IN BRIEF: Silence Therapeutics Begins Dosing In SLN360 Phase 1 Trial

Silence Therapeutics begins dosing in lipoprotein treatment trial
17 Feb 2021

Silence Therapeutics begins dosing in lipoprotein treatment trial

(Sharecast News) - Silence Therapeutics has started dosing subjects in the 'APOLLO' phase 1 clinical study of its wholly-owned lead product candidate ...

Silence Therapeutics Raises USD45 Million In Private Share Placing
5 Feb 2021

Silence Therapeutics Raises USD45 Million In Private Share Placing

Silence Therapeutics Raises USD45 Million In Private Share Placing

Silence Therapeutics raises ?33m to support pipeline development
5 Feb 2021

Silence Therapeutics raises ?33m to support pipeline development

(Sharecast News) - Novel therapeutics developer Silence Therapeutics announced an oversubscribed private placement of 2,022,218 American depositary sh...

UK EXECUTIVE CHANGE SUMMARY: Martin Gilbert Joins River & Mercantile
6 Jan 2021

UK EXECUTIVE CHANGE SUMMARY: Martin Gilbert Joins River & Mercantile

UK EXECUTIVE CHANGE SUMMARY: Martin Gilbert Joins River & Mercantile

Silence Therapeutics taps Craig Tooman for CFO
6 Jan 2021

Silence Therapeutics taps Craig Tooman for CFO

(Sharecast News) - Drug discovery outfit Silence Therapeutics has named Craig Tooman as its new chief financial officer.

UK DIRECTOR DEALINGS SUMMARY: Tesco's Simon Patterson Buys Shares
12 Oct 2020

UK DIRECTOR DEALINGS SUMMARY: Tesco's Simon Patterson Buys Shares

UK DIRECTOR DEALINGS SUMMARY: Tesco's Simon Patterson Buys Shares

e-Therapeutics Names New Chief Executive; Plans To Ramp Up Research
12 Oct 2020

e-Therapeutics Names New Chief Executive; Plans To Ramp Up Research

e-Therapeutics Names New Chief Executive; Plans To Ramp Up Research